申请人:Catabasis Pharmaceuticals, Inc.
公开号:US20140249189A1
公开(公告)日:2014-09-04
The invention relates to fatty acid niacin conjugates; compositions comprising an effective amount of a fatty acid niacin conjugate; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid niacin conjugate.
本发明涉及
脂肪酸烟酸共轭物;包含有效量
脂肪酸烟酸共轭物的组合物;以及使用有效量
脂肪酸烟酸共轭物进行治疗或预防代谢性疾病的方法。